Resource Library

As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these trials more and more, researchers have come to appreciate the significance of establishing uniform approaches for evaluating and analyzing real-world data (RWD).

Castor announces the appointment of Brad Hightower, a leading clinical trials executive, to its advisory board.

As we kick-off 2023 with a refreshed mindset, we take inventory of what is important and focus on our goal to continuously make sure that we are maximizing the impact of data on the global disease burden with more inclusive, patient-friendly trials.

Martijn Kersloot, PhD, Product Owner at Castor, gives an introduction into the FAIR Data Principles and highlights why collecting machine-readable data is crucial

Learn best practices on RWE, Castor’s offerings for collecting RWD, and 3 different RWE case studies from Castor clients

Learn key compliance requirements, data collection tips, and important dates for the EU Medical Device Regulation in this white paper.

Castor’s ePRO solution enabled AKRN and Company Z to engage with a participant population that, on their own, might struggle with a technology solution that they’ve never used before.

An electronic data capture (EDC) system is software used to collect, clean, transfer, process, and store data in clinical trials. EDCs are used by contract research organizations (CROs), sponsors, and sites to conduct both simple and complex clinical trials in all phases of research.

There are ongoing debates about whether or not our industry should call all decentralized ones digital trials; however, most of us need help understanding the fundamental step to successfully operate both types of trials, which is effective data monitoring.

Real-world evidence has the potential to transform evidence based medicine, by generating a body of evidence that provides a much more accurate view on what cure is best for each individual patient.